Microbial Testing Market Share, Opportunities, Industry 2031

Segments - Microbial Testing Market by Types (Instruments and Reagents), Applications (Pharmaceutical, Clinical, Food Testing, Energy, Chemical and Material Manufacturing, and Environment), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global microbial testing market size was valued USD 3.9 billion in 2020 and is projected to reach USD 5.3 billion by 2028 at a CAGR of 6.5% during the forecast period, 2021-2028. The growth of the market is attributed to rising incidence of infectious diseases such as HIV, human papillomavirus (HPV), and hepatitis B and C.

Several emerging molecular diagnostic techniques are being used more frequently for early detection and effective treatment of pathogen-borne diseases. When compared to traditional laboratory techniques, advanced molecular diagnostic techniques provide several technological advantages such as faster turnaround time, high sample throughput, multiplexing of reactions, specificity, improved accuracy, and increased device sensitivity. NGS, real-time PCR, molecular cartridges, and PCR coupled with mass spectrometry are among the advanced molecular diagnostic techniques that are increasingly becoming acknowledged for their ability to identify and characterize various pathogens as well as analyze samples in a single run.

Market Trends, Drivers, Restraints, and Opportunities

Technological advancements in microbiology testing is anticipated to drive the market growth.
The outbreaks of epidemics such as COVID 19 and rising healthcare expenditure are expected to foster the growth of the market/
Rising private-public funding for infectious disease research are driving the growth of the microbiology testing market.
The presence of robust medical infrastructure, such as hospitals and clinical labs in emerging economies and low-income countries is estimated to propel the market growth.
High cost of tests can create challenges for the growth of the market in the projected timeline.
Rising geriatric population and increasing clinical research in clinical microbiology are anticipated to proliferate the growth of the market during the forecast period.

Scope of Microbial Testing Market Report

The report on the global microbial testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Microbial Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2021
Historic Data	2019–2020
Forecast Period	2021–2028
Segmentation	Types (Instruments and Reagents) and Applications (Pharmaceutical, Clinical, Food Testing, Energy, Chemical and Material Manufacturing, and Environment)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Quidel Corporation; Dickinson and Company; F. Hoffmann-La Roche Ltd.; Thermo-Fischer Scientific, Inc.; and Gen-Probe; and Danaher.

Microbial Testing Market Segment Insights

Instruments segment to account a major market share

Based on types, the market is divided into instruments and reagents. The instruments segment to hold a large market share in the projected timeline. Microbiology equipment is a broad category that encompasses a wide range of instruments used in microbiology labs. Microscopes, slides, test tubes, petri dishes, solid and liquid growth mediums, inoculation loops, pipettes and tips, incubators, autoclaves, and laminar flow hoods are few examples of microbiology equipment.

A reagent is a material or ingredient that is added to a system to either produce or test a chemical reaction. The reactants are usually referred to as substrates in biochemistry, especially when enzyme-catalyzed reactions are involved. The reagent segment is anticipated to grow at a robust rate during the forecast period.

Pharmaceutical segment to hold a major market share

On the basis of applications, the microbial testing market is segregated into pharmaceutical, clinical, food testing, energy, chemical and material manufacturing, and environment. The pharmaceutical segment is expected to dominate the market. The presence of well-established and acknowledgments of rules that control the evaluation of microbiological contamination during pharmaceutical manufacturing and raw material sourcing are largely responsible for this segment's substantial share. To assure sanitization, several regulatory authorities such WHO, FDA, and the Medicines and Healthcare Products Regulatory Agency (MHRA, UK)] have well-defined regulatory criteria for the evaluation of microbiological contamination in excipients and APIs.

North America is projected to hold a major market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2020, in terms of revenue. Clinical microbiology technologies are widely used among key end-users such as hospitals, diagnostic centers, research laboratories, and commercial service providers in North America, which has well-established distribution channels for clinical microbiology product manufacturers and suppliers. The high adoption of modern diagnostic technologies, as well as supporting government policies in the US and Canada are further driving the growth of the market in the region.

Segments

The global microbial testing market is segmented on the basis of

Types

Instruments
Reagents

End-users

Pharmaceutical
Clinical
Food Testing
Energy
Chemical
Material Manufacturing
Environment

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Quidel Corporation
F. Hoffmann-La Roche Ltd.
Dickinson and Company
Thermo-Fischer Scientific, Inc.
Gen-Probe
Danaher

Competitive Landscape

The major players in the microbial testing market include Quidel Corporation, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo-Fischer Scientific, Inc., Gen-Probe and Danaher.

Companies are engaging in mergers, acquisitions and partnerships to expand their market share. Danaher is a well-known name in the field of clinical microbiology. Beckman Coulter and Cepheid, the company's wholly-owned subsidiaries, operate in the clinical microbiology testing sector. Danaher is primarily focusing on leveraging its market position in the global microbiology/clinical testing market through acquisitions and product releases.

Global Microbial Testing Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microbial Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Microbial Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Microbial Testing Market - Supply Chain
  4.5. Global Microbial Testing Market Forecast
     4.5.1. Microbial Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Microbial Testing Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Microbial Testing Market Absolute $ Opportunity
5. Global Microbial Testing Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Microbial Testing Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Microbial Testing Demand Share Forecast, 2019-2026
6. North America Microbial Testing Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Microbial Testing Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Microbial Testing Demand Share Forecast, 2019-2026
7. Latin America Microbial Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Microbial Testing Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Microbial Testing Demand Share Forecast, 2019-2026
8. Europe Microbial Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Microbial Testing Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Microbial Testing Demand Share Forecast, 2019-2026
9. Asia Pacific Microbial Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Microbial Testing Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Microbial Testing Demand Share Forecast, 2019-2026
10. Middle East & Africa Microbial Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Microbial Testing Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Microbial Testing Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Microbial Testing Market: Market Share Analysis
  11.2. Microbial Testing Distributors and Customers
  11.3. Microbial Testing Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Quidel Corporation
     11.4.2. Dickinson and Company
     11.4.3. F. Hoffmann-La Roche Ltd.
     11.4.4. Thermo-Fischer Scientific, Inc.
     11.4.5. Gen-Probe
     11.4.6. Danaher